Rating upgrades and recent acquisitions and divestiture mean Becton Dickinson (BDX) has a lower risk profile and superior growth prospects. I last reviewed Becton Dickinson (BDX) in this November 13, 2021 post. At the time, BDX had announced its intent to spin off its Diabetes Care business as part of its 2025 Strategy - Grow, [...]
In my opinion, Intercontinental Exchange (ICE) currently offers growth at a fair valuation. I last analyzed ICE in my May 6, 2022 post, at which time I provided a brief overview of the company and the proposed acquisition of Black Knight, Inc. (BKI). This $13.1B cash and stock transaction ($85/share which is in line with [...]
S&P Global (SPGI) is a great long-term investment but investors would be wise to wait for a better valuation. I last reviewed SPGI in this May 5, 2022 post following the release of Q1 2022 results. My Final Thoughts in that post are: S&P Global is accelerating revenue prospects in high-growth markets which bodes well [...]
Intact Financial (IFC), a fragmented Canadian insurance market leader, holds a ~20% market share in the property and casualty insurance space; the top 5 hold a ~49% market share. Not only is IFC a market leader in Canada but it is becoming a specialty solutions leader and following various strategic acquisitions, it now has access [...]
On July 27, 2022, Automatic Data Processing (ADP) released strong Q4 and FY2022 results and an encouraging FY2023 outlook. Despite an increase in ADP's adjusted diluted EPS guidance relative to FY2022 results, the sudden surge in ADP's share price has led to a slight deterioration in its valuation from the time of my last [...]
In my recent CME Group – The Risk Of Relying On Stock Screeners post, I disclose that all the stock screeners I have reviewed reflect incorrect dividend metrics when a company has a special variable dividend policy. Rollins, Inc. (ROL), like CME, has a special variable dividend policy. I last reviewed ROL in my April [...]
Some investors rely exclusively on stock screeners to make investment decisions. CME Group, with its unique dividend policy, is a good example of the risk of relying on stock screeners to make investment decisions. Looking at several different stock screeners in preparation for this post, I see not one that accurately reflects CME's dividend yield! [...]
Raytheon Technologies (RTX), a defense and commercial aerospace powerhouse, is benefitting from an increasingly hostile global political climate. I last reviewed RTX in my January 26, 2022 post at which time it had just released its Q4 and FY2021 results and FY2022 outlook. RTX has now released Q2 and YTD2022 results and its FY2022 outlook [...]
Investors should invest in great companies, such as Moody's Corporation (MCO), when they temporarily fall out of favour. I have been increasing my exposure to wide moat MCO on weakness. I last reviewed MCO in my May 4, 2022 Moody's Current Headwinds Present a Buying Opportunity post. At the time, it had just reported Q1 [...]
I last reviewed Intuitive Surgical (ISRG) in my April 23, 2022 post at which time it had just released Q1 2022 results. Following the July 21 market close, ISRG released Q2 results. It continues to experience headwinds from: COVID-driven lockdowns in China, ISRG's 2nd largest market; supply chain disruptions with semiconductor component delays impacting the [...]
